Use of novel, non-imidazole inverse agonist radioligands to define histamine H3 receptor pharmacology.

Inflamm Res

Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL 60064, USA.

Published: April 2005

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00011-004-0421-yDOI Listing

Publication Analysis

Top Keywords

novel non-imidazole
4
non-imidazole inverse
4
inverse agonist
4
agonist radioligands
4
radioligands define
4
define histamine
4
histamine receptor
4
receptor pharmacology
4
novel
1
inverse
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!